Product

NaCl powder

1 clinical trial

1 indication

Indication

Clinical trial

Randomized, Open-label Study to Evaluate the Efficacy of Breathox Device Inhalation Therapy in the Treatment of Acute Symptoms Associated With COVID-19 and in the Prevention of the Use of Health Resources in Patients With ≥ 18 Years Old

Status: Completed, Estimated PCD: 2022-07-01